Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema

Intraocular anti-vascular endothelial growth factor (VEGF) therapies are the front-line treatment for diabetic macular edema (DME); however, treatment response varies widely. This study aimed to identify genetic determinants associated with anti-VEGF treatment response in DME. We performed a genome-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurung, Rajya L., FitzGerald, Liesel M., Liu, Ebony, McComish, Bennet J., Kaidonis, Georgia, Ridge, Bronwyn, Hewitt, Alex W., Vote, Brendan J., Verma, Nitin, Craig, Jamie E., Burdon, Kathryn P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999697/
https://www.ncbi.nlm.nih.gov/pubmed/35409401
http://dx.doi.org/10.3390/ijms23074042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999697/
https://www.ncbi.nlm.nih.gov/pubmed/35409401
http://dx.doi.org/10.3390/ijms23074042

Ejemplares similares